摘要
肥胖会导致多种代谢紊乱,不幸的是,目前针对肥胖的药物治疗并不十分有效。在摄食机制中,下丘脑和一些神经肽起着重要作用。许多数据表明神经肽Y (neuropeptide Y, NPY)参与了这些机制。本综述的目的是更新由促性腺激素NPY通过其受体介导的控制食物摄入的生理作用,并回顾其在食物摄入障碍中的参与情况。本文将讨论NPY与其他涉及食物摄入机制、下丘脑和下丘脑外通路的物质之间的关系,以及治疗肥胖的潜在药理策略。提出了今后以NPY为重点的研究方向。神经肽系统与冗余相关,针对单一目标的治疗通常无效。因此提到了治疗肥胖的其他靶点。联合治疗似乎是成功抗肥胖治疗的最佳选择:新的和更特异的NPY受体拮抗剂必须作为抗肥胖药物单独和联合治疗进行测试。
关键词: 摄食,暴饮暴食,NPY, NPY受体,肥胖,促食肽,单核苷酸多态性。
Current Medicinal Chemistry
Title:Regulation of Homeostasis by Neuropeptide Y: Involvement in Food Intake
Volume: 29 Issue: 23
关键词: 摄食,暴饮暴食,NPY, NPY受体,肥胖,促食肽,单核苷酸多态性。
摘要: Obesity leads to several metabolic disorders and, unfortunately, current pharmacological treatments for obesity are not very effective. In feeding mechanisms, the hypothalamus and some neuropeptides play an important role. Many data show that neuropeptide Y (NPY) is involved in these mechanisms. The aim of this review is to update the physiological actions mediated by the orexigenic peptide NPY, via its receptors, in the control of food intake and to review its involvement in food intake disorders. The relationships between NPY and other substances involved in food intake mechanisms, hypothalamic and extra-hypothalamic pathways involved in feeding and the potential pharmacological strategies to treat obesity will be discussed. Some research lines, focused on NPY, to be developed in the future are suggested. Neuropeptide systems are associated with redundancy and then therapies directed against a single target are generally ineffective. For this reason, other targets for the treatment of obesity are mentioned. It seems that combination therapies are the best option for successful anti-obesity treatments: new and more specific NPY receptor antagonists must be tested as anti-obesity drugs alone and in combination therapies.
Export Options
About this article
Cite this article as:
Regulation of Homeostasis by Neuropeptide Y: Involvement in Food Intake, Current Medicinal Chemistry 2022; 29 (23) . https://dx.doi.org/10.2174/0929867328666211213114711
DOI https://dx.doi.org/10.2174/0929867328666211213114711 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements